| First Author | Fujiki H | Year | 2012 |
| Journal | Cancer Lett | Volume | 324 |
| Issue | 2 | Pages | 119-25 |
| PubMed ID | 22626556 | Mgi Jnum | J:189296 |
| Mgi Id | MGI:5445023 | Doi | 10.1016/j.canlet.2012.05.012 |
| Citation | Fujiki H, et al. (2012) Green tea: an effective synergist with anticancer drugs for tertiary cancer prevention. Cancer Lett 324(2):119-25 |
| abstractText | Green tea is now an acknowledged cancer preventive in Japan. Based on evidence that colorectal adenomas and prostate cancer in humans have been prevented, we review here the concept that the combination of anticancer drugs with green tea catechin synergistically induces apoptosis of human cancer cells, inhibits tumor formation in mice, and enhances inhibition of tumor growth in xenograft mouse models. As a molecular mechanism by the combination, the induction of growth arrest and DNA damage-inducible 153 (GADD153, CHOP) gene expression is discussed in relation to death receptor 5 and TRAIL-apoptotic pathway. The combination of anticancer drugs with green tea could be a new cancer therapeutic strategy in humans. |
